Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Depreciation & Amortization (CF) (2024 - 2025)

Carlsmed (CARL) has disclosed Depreciation & Amortization (CF) for 2 consecutive years, with $98000.0 as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Depreciation & Amortization (CF) rose 164.86% year-over-year to $98000.0, compared with a TTM value of $317000.0 through Dec 2025, changed N/A, and an annual FY2025 reading of $281000.0, up 93.79% over the prior year.
  • Depreciation & Amortization (CF) was $98000.0 for Q4 2025 at Carlsmed, up from $82000.0 in the prior quarter.
  • Across five years, Depreciation & Amortization (CF) topped out at $100000.0 in Q2 2025 and bottomed at $33000.0 in Q3 2024.